Skip to main content
Erschienen in: Reactions Weekly 1/2017

01.06.2017 | Case report

Ponatinib

Ischaemic stroke secondary to hypercoagulability: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literatur
Zurück zum Zitat Pande A, et al. Pseudozyma and other non-Candida opportunistic yeast bloodstream infections in a large stem cell transplant center. Transplant Infectious Disease 19: e12664, No. 2, Apr 2017. Available from: URL: http://doi.org/10.1111/tid.12664 - USA Pande A, et al. Pseudozyma and other non-Candida opportunistic yeast bloodstream infections in a large stem cell transplant center. Transplant Infectious Disease 19: e12664, No. 2, Apr 2017. Available from: URL: http://​doi.​org/​10.​1111/​tid.​12664 - USA
Metadaten
Titel
Ponatinib
Ischaemic stroke secondary to hypercoagulability: case report
Publikationsdatum
01.06.2017
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2017
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-017-31280-x

Weitere Artikel der Ausgabe 1/2017

Reactions Weekly 1/2017 Zur Ausgabe

Case report

Rituximab

Case report

Multiple drugs